(Reuters) – Regeneron Pharmaceuticals Inc said on Friday the U.S. Food and Drug Administration updated the emergency use authorization for its COVID-19 antibody cocktail, allowing the use of the drug at half the originally authorized dose.
(Reporting by Manojna Maddipatla in Bengaluru; Editing by Arun Koyyur)
